Hashmi Kashif A, Adnan Fahar, Ahmed Omer, Yaqeen Syed Rafay, Ali Javaria, Irfan Muhammad, Edhi Muhammad M, Hashmi Atif A
Cardiology, Chaudhry Pervaiz Elahi Institute of Cardiology, Multan, PAK.
Cardiology, Jinnah Hospital, Lahore, PAK.
Cureus. 2020 Dec 21;12(12):e12209. doi: 10.7759/cureus.12209.
Introduction The Killip classification system was introduced for clinical assessment of patients with acute myocardial infarction (MI). It stratifies individuals according to the severity of their post-MI heart failure. This system provides effective stratification of long-term and short-term outcomes in patients with acute MI and influences the treatment strategies. Revalidation of Killip class in our local population is mandatory. We planned this study to increase cardiologist's readiness to tackle the risks associated with increased mortality in each class post ST-segment elevation MI (STEMI). Objectives were to determine the frequency of Killip classes I, II, III, and IV and in-hospital mortality in each Killip class in patients with left ventricular failure secondary to STEMI. Methods A retrospective cross-sectional study was conducted in the Department of Cardiology, Jinnah Hospital, Lahore, over a period of three years. Patients with STEMI were stratified using Killip classification, and validation was performed by determining the within 15 days in-hospital mortality in each Killip class. Results The frequency (percentage) of patients with STEMI in each Killip class from I to IV was 395 (81.4%), 46 (9.5%), 27 (5.6%), and 17 (3.5%), respectively, while the in-hospital mortality in each Killip class came out to be 39 (9.9%), 4 (8.7%), 25 (92.6%) and 17 (100%), respectively. The presence of diabetes, history of smoking, and body mass index (BMI) of more than 30 kg/m were significant contributors to mortality, along with higher Killip class and age of presentation. Conclusions It is concluded that the Killip classification system is a valid tool for risk stratification for patients after STEMI, especially in resource-limited countries.
引言 基利普分类系统用于急性心肌梗死(MI)患者的临床评估。它根据心肌梗死后心力衰竭的严重程度对个体进行分层。该系统为急性心肌梗死患者的长期和短期预后提供了有效的分层,并影响治疗策略。在我们当地人群中重新验证基利普分级是必要的。我们开展这项研究是为了提高心脏病专家应对ST段抬高型心肌梗死(STEMI)后各分级中死亡率增加相关风险的准备程度。目的是确定STEMI继发左心室衰竭患者中基利普I、II、III和IV级的频率以及各基利普分级中的院内死亡率。
方法 在拉合尔真纳医院心脏病科进行了一项为期三年的回顾性横断面研究。采用基利普分类对STEMI患者进行分层,并通过确定各基利普分级在15天内的院内死亡率来进行验证。
结果 STEMI患者中基利普I至IV级的频率(百分比)分别为395(81.4%)、46(9.5%)、27(5.6%)和17(3.5%),而各基利普分级的院内死亡率分别为39(9.9%)、4(8.7%)、25(92.6%)和17(100%)。糖尿病、吸烟史以及体重指数(BMI)超过30kg/m²是死亡率的重要影响因素,同时基利普分级越高和就诊年龄越大也是影响因素。
结论 得出结论,基利普分类系统是STEMI后患者风险分层的有效工具,尤其是在资源有限的国家。